Sign In

CPG Infobase: Clinical Practice Guidelines


The CPG Infobase is a database of evidence-based Canadian clinical practice guidelines (CPGs). Maintained by Joule™, a CMA company, it includes approximately 1,200 CPGs developed or endorsed by authoritative medical or health organizations in Canada.

List of Guidelines

For Subject: Drug Therapy
Number of CPGs:  105

  • Results 1-10
1.
2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure

View HTML
2017-Nov
Canadian Cardiovascular Society

Detailed Result

2.
Canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth

View HTML
2017-Sept
Canadian Schizophrenia Guidelines Working Group

Detailed Result

3.
Canadian treatment guidelines for individuals at clinical high risk of psychosis

View HTML
2017-Sept
Canadian Schizophrenia Guidelines Working Group

Detailed Result

4.
Guidelines for the pharmacotherapy of schizophrenia in adults

View HTML
2017-Sept
Canadian Schizophrenia Guidelines Working Group

Detailed Result

5.
Systemic therapy for recurrent epithelial ovarian cancer

View PDF
2017-July
Cancer Care Ontario's Program in Evidence-based Care

Detailed Result Guideline Summary 

6.
CUA guideline on adult overactive bladder

View PDF
2017-May
Canadian Urological Association

Detailed Result Guideline Summary 

7.
Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults

View PDF
2017-Apr
Hypertension Canada - Canadian Hypertension Education Program

Detailed Result

8.
Cognitive impairment : part 2: diagnosis to management

View PDF
2017-Feb
Toward Optimized Practice [Alberta]

Detailed Result Guideline Summary  Other Related Documents

9.
Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: an update.

View PDF
2016-Nov
Hypertension Canada - Canadian Hypertension Education Program

Detailed Result

10.
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder Section 3. Pharmacological treatments

View PDF
2016-Sept
Canadian Network for Mood and Anxiety Treatments

Detailed Result



Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.